Leukoaraiosis
6
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Florida Cerebrovascular Disease Biorepository and Genomics Center
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
Leucoaraiosis and Multimodal MRI With Fingerprinting Technique
Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage
the Effects of Cerebral Collateral Circulation on the Outcome of Leukoaraiosis in High-risk Population
The Relationship Between White Matter Hyperintensity With Cognition and Emotion